MorphoSys and Incyte Announce Acceptance by Health Canada of the New Drug Submission for Tafasitamab
PLANEGG/MUNICH, GERMANY and MONTREAL, QC / ACCESSWIRE / January 12, 2021 / MorphoSys AG (FSE:MOR; Prime Standard Segment; MDAX &...
PLANEGG/MUNICH, GERMANY and MONTREAL, QC / ACCESSWIRE / January 12, 2021 / MorphoSys AG (FSE:MOR; Prime Standard Segment; MDAX &...
DGAP-News: MorphoSys AG / Key word(s): Miscellaneous MorphoSys and Incyte Announce Acceptance by Health Canada of the New Drug Submission...
WhatsApp us